Streetbeat News

MTAC

MedTech Acquisition Corp

Open

9.35

Mkt cap

84M

Volume

176K

High

12.83

P/E Ratio

226.80

52-wk high

12.83

Low

8.96

Div yield

N/A

52-wk low

8.43

TriSalus Life Sciences has completed its merger with MedTech Acquisition Corporation. The merger is expected to advance TriSalus' technology development and sales growth, and provide a cash runway through mid-2024. TriSalus' common stock and warrants are expected to commence trading on the Nasdaq Global Market under the ticker symbols 'TLSI' and 'TLSIW', respectively, on August 11, 2023.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 8:54 pm

Shares of MedTech Acquisition Corp have resumed trading.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 7:14 pm

Shares of MedTech Acquisition Corp (MTAC) were halted on a circuit breaker due to a sharp increase in price. The stock is now up by 22.4%.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 7:10 pm

TriSalus Life Sciences presented additional data for SD-101 delivered via the exclusive PEDDT method with the TriNav device, amid its merger with MedTech Acquisition Corporation (MTAC).

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 11:17 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.